Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Acorda Therapeutics Inc    ACOR

Delayed Quote. Delayed  - 04/29 09:59:59 pm
25.85 USD   -5.45%
01:00p ACORDA THERAPEU : to Present at Two Investor Conferences in May
04/28 ACORDA THERAPEU : reports 1Q loss
04/28 ACORDA THERAPEU : Provides Financial and Pipeline Update for First Q..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
30.06(c) 29.04(c) 28.91(c) 27.34(c) 25.85 Last
411 955 569 316 373 298 571 336 772 866 Volume
-0.20% -3.39% -0.45% -5.43% -5.45% Change
More quotes
Financials ($)
Sales 2016 516 M
EBIT 2016 -2,26 M
Net income 2016 -15,4 M
Debt 2016 54,7 M
Yield 2016 -
Sales 2017 572 M
EBIT 2017 11,1 M
Net income 2017 -12,6 M
Debt 2017 68,9 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 2,53x
EV / Sales 2017 2,31x
Capitalization 1 251 M
More Financials
Company
Acorda Therapeutics, Inc. develops and markets therapeutic products for nervous system disorders.The company's two main products are Ampyra and Zanaflex Capsules.The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short... 
More about the company
Surperformance© ratings of Acorda Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACORDA THERAPEUTICS INC
01:00p ACORDA THERAPEUTICS : to Present at Two Investor Conferences in May
04/28 ACORDA THERAPEUTICS : Announces Results from Phase 2b Clinical Trial of CVT-301 ..
04/28 ACORDA THERAPEUTICS INC : Results of Operations and Financial Condition, Financi..
04/28 ACORDA THERAPEUTICS : reports 1Q loss
04/28 ACORDA THERAPEUTICS : Provides Financial and Pipeline Update for First Quarter 2..
04/25ACORDA THERAPEUTICS INC : quaterly earnings release
04/21 ACORDA THERAPEUTICS : Phase 2b Data on Inhaled Levodopa CVT-301 Featured in Invi..
04/20 ACORDA THERAPEUTICS : Announces Results from Phase 2b Clinical Trial of CVT-301 ..
More news
Sector news : Bio Therapeutic Drugs
04:29pDJMedivation Rejects Sanofi's $9.3 Billion Takeover Bid--Update
04:15pDJMedivation Rejects Sanofi's Takeover Bid
04:01pDJMedivation Rejects Sanofi's $9.3 Billion Takeover Bid
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
04/28 Acorda Therapeutics (ACOR) Q1 2016 Results - Earnings Call Webcast
04/28 Acorda Therapeutics misses by $0.01, beats on revenue
04/27 Notable earnings before Thursday?s open
04/12 Politicians Are Targeting Biotech - Cramer's Lightning Round (4/11/16)
04/01 Healthcare ratings roundup - new coverage #1


Comments 
Advertisement
Chart ACORDA THERAPEUTICS INC
Duration : Period :
Acorda Therapeutics Inc Technical Analysis Chart | ACOR | US00484M1062 | 4-Traders
Full-screen chart
Technical analysis trends ACORDA THERAPEUTI...
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions